Generics BulletinTorrent Pharmaceuticals Ltd has struck an acquisition deal for JB Chemicals and Pharmaceuticals Ltd, buying out the entire 46.4% stake of private equity (PE) firm KKR and making an offer to acquire a
Generics BulletinIn a financial third quarter of ups and downs, India’s Torrent Pharmaceuticals managed to offset currency headwinds in Brazil and a downturn in its US business thanks to double-digit growth in India a
Generics BulletinBoehringer Ingelheim is cashing in on its diabetes franchise related to sodium glucose co-transporter-2 (SGLT-2) inhibitor empagliflozin in India ahead of the local patent expiry for the molecule in M
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Kaken Obtains Aadi’s Fyarro, Comm